Part B Drugs At Home: Medicare Policy Responds To COVID-Driven Access Concerns

 
• By Cathy Kelly
  
Intravenous drip
Instead of an intravenous drip, policy change in the coronavirus era has felt more like a bolus.

More from Market Access

More from Pink Sheet